MTNB icon

Matinas BioPharma
MTNB

Overview Fund Activity

47 hedge funds and large institutions have $27.7M invested in Matinas BioPharma in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 12 closing their positions.

Holders
47
Holders Change
-7
Holders Change %
-12.96%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
13
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.28M
2
SCA
2
STALEY CAPITAL ADVISERS
Pennsylvania
$171K
3
Bank of New York Mellon
3
Bank of New York Mellon
New York
$132K
4
Wells Fargo
4
Wells Fargo
California
$88K
5
Northern Trust
5
Northern Trust
Illinois
$203K

Top Sellers

1
BC
1
Broadfin Capital
New York
$657K
2
SCM
2
Stonepine Capital Management
Oregon
$573K
3
JGC
3
J. Goldman & Co
New York
$0
4
CH
4
CVI Holdings
Delaware
$0
5
Millennium Management
5
Millennium Management
New York
$489K
Name Holding Trade Value Shares
Change 		Shares
Change %
TEE
51
Tibra Equities Europe
United Kingdom
– -$264K -4,839 Closed
Barclays
52
Barclays
United Kingdom
– -$74K -1,353 Closed
Goldman Sachs
53
Goldman Sachs
New York
– -$66K -1,208 Closed
ECM
54
ExodusPoint Capital Management
New York
– -$42K -764 Closed
Bank of America
55
Bank of America
North Carolina
– -$34K -622 Closed
UBS Group
56
UBS Group
Switzerland
– -$12K -216 Closed
AIC
57
Ameritas Investment Company
Nebraska
– -$6K -112 Closed
CHP
58
Cable Hill Partners
Oregon
– -$1K -20 Closed
1 2
3